Sigve Andersen
Job description
Mitt forskningsområde er hovedsaklig translasjonell kreftforskning på lungekreft. Jeg er også involvert i forskning innen andre tumorgrupper som prostata, kolorektalkreft og innen fagfeltet palliasjon. Min undervisning er hovedsaklig orientert rundt palliasjon, men også generell kreft. Jeg er også fast medlem i eksamenskommisjonen for avsluttende eksamen.
Marianne Jensen,
Aleksandra,
Nina Kathrine,
Sigve,
Guro Lindviksmoen,
Olav
et al.:
PALLiative care in ONcology (PALLiON): A cluster-randomised trial investigating the effect of palliative care on the use of anticancer treatment at the end of life
Dagny,
Thomas Karsten,
Mona Irene,
Egil Støre,
Ilona Halva,
Erna-Elise
et al.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Marie Grøn,
Line Veronika,
Erling Johan,
Tore,
Sigve,
Anne Gry
et al.:
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Hallgeir,
Lill-Tove Rasmussen,
Sigve,
Mona Irene,
Ana Paola,
Thomas Karsten
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
Erna-Elise,
Sigve,
Mehrdad,
Mona Irene,
Ana Paola,
Mette
et al.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad,
Sigve,
K.,
Erna-Elise,
Thomas Karsten,
Lill-Tove Rasmussen
et al.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Line Veronika,
Marie Grøn,
Erling Johan,
Tore,
Sigve,
Anne Gry
et al.:
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Hallgeir,
Sigve,
Mona Irene,
Ana Paola,
Lill-Tove Rasmussen,
Thomas Karsten
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
Therese Haugdahl,
Anne Heidi,
Ilona Halva,
Robin,
Erna-Elise,
Tom
et al.:
Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer
Mehrdad,
Elio,
Biagio,
Lynette M. Sholl,
Weiwei,
Joao V.
et al.:
Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC
JAMA Oncology 17. November 2022 DOI
Hallgeir,
Lill-Tove Rasmussen,
Sigve,
Roy M.,
Thomas Karsten
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
Sissel Gyrid Freim,
Yan Dai,
Elisabeth Fritzke,
Thomas,
Tarje Onsøien,
Anine Larsen
et al.:
The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study
Maria Jenvin,
Sigve,
Mehrdad,
Mona I.,
Lise Martine,
Tom
et al.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Maria Jenvin,
Sigve,
Mehrdad,
Mona Irene,
Lise Martine,
Roy M.
et al.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Håkon Andre,
Elin,
Gustavo Antonio De,
Mehrdad,
Maria,
Peder Rustøen
et al.:
Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer
Mehrdad,
Thomas Karsten,
Simin,
Thomas,
Erna-Elise,
Marte
et al.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021 DOI
Thomas Karsten,
Erna-Elise,
Sigve,
Mehrdad,
Roy M.,
Lill-Tove Rasmussen
et al.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Bente,
Sigve,
Helge,
Tom
:
Evaluating a centralised cancer support centre in the remote region of Northern Norway
Elin,
Sigve,
Christian,
Mehrdad,
Nora,
Samer
et al.:
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
Mehrdad,
Lill-Tove,
Simin,
Erna-Elise,
Elin,
Sigve
et al.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Elin,
Sigve,
Samer,
Mehrdad,
Yngve,
Mona Irene
et al.:
Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
Kaja Konstanse,
Charles,
Thea K.W.,
Thomas Karsten,
Erna Elise,
Mona Irene
et al.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Thea K.W.,
Elin,
Sigve,
Kaja Konstanse,
Mehrdad,
Tom
et al.:
Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression
Yury,
Sigve,
Charles,
Bjørn,
Karina Standahl,
Helge
et al.:
Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
Mehrdad,
Thomas Karsten,
Stig Manfred,
Elin,
Erna Elise,
Sigurd
et al.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Human Pathology 2018 DOI
Sigurd,
Mehrdad,
Inigo Zubiavrre,
Elin,
Samer,
Erna Elise
et al.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018 DOI
Nora,
Sigve,
Mehrdad,
Cecilie,
Andrey Yurjevich,
Erna-Elise
et al.:
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
Yngve,
Elin,
Nora,
Tom,
Hitendra R.H.,
Lill-Tove
et al.:
High miR-205 expression in normal epithelium is associated with biochemical failure - An argument for epithelial crosstalk in prostate cancer?
Stein,
Dagny Renata Faksvåg,
Sigve,
Nina Kathrine,
Anne Tove,
Eva-Kristin Norum
et al.:
Regjeringen gir dødshjelp til palliativ medisin
2024
falah,
Sigve,
Erna-Elise,
Masoud,
Elin Helmine,
Sissel Gyrid Freim
et al.:
Integrating Artificial intelligence (AI)-based lymphocytic infiltration assessment in early-stage NSCLC: A sub-study of the TNM-I trial
2024
Øyvind,
Sigve,
Stian,
Åslaug
:
Stian har livstruende lungekreft: – Jeg er beviset på at forskning nytter
08. Juni 2023
Marianne Jensen,
Aleksandra,
Nina Kathrine,
Sigve,
Guro Lindviksmoen,
Olav
et al.:
1592MO Anticancer therapy at the end-of-life: A cluster-randomized trial
Annals of Oncology 2023 DOI
Tonje,
Nina Kathrine,
Sigve,
Sjur Bjørnar,
Marianne Jensen,
Stein
et al.:
Family carers' experiences with brain metastases: A longitudinal study
2023
Mehrdad,
Elio,
Biagio,
Lynette M.,
Weiwei,
Joao V
et al.:
Computational pathology by Artificial Intelligence (AI) on quantifying the lymphocytic infiltration predicts the immunotherapy response in NSCLC
2022
Mehrdad,
Elio,
Biagio,
Lynette M.,
Joao,
Alessio
et al.:
Digital quantification of lymphocytic infiltration on routine H&E images and immunotherapy response in non-small cell lung cancer
2022
Mehrdad,
Elio,
Biagio,
Lynette M.,
Weiwei,
Joao
et al.:
Artificial intelligence in digital pathology approach identifies the predictive impact of tertiary lymphoid structures with immune-checkpoints therapy in NSCLC
2022
Ilona H.,
Therese Haugdahl,
Anne Heidi,
Robin,
Erna-Elise,
Tom
et al.:
Increased Levels of mRNAs and miRNAs Associated with Imminent and Advanced Lung Cancer
Journal of Thoracic Oncology 2022 DOI
Therese Haugdahl,
Ilona Halva,
Anne Heidi,
Robin,
Erna Elise,
Tom
et al.:
Increased levels of mRNAs and miRNAs associated with imminent and advanced lung cancer
2022
Stein,
Marianne,
Sigve,
Peder,
Helge,
Anne Marie
et al.:
De er døende. Gi dem lindring
2020
Marianne,
Sigve,
Peder,
Helge,
Anne Marie,
Søren Vincent
et al.:
Organisering av det palliative tilbudet
Faglig begrunnet eller et udemokratisk politisk spill?
24. August 2020
Marianne Jensen,
Nina Kathrine,
Sigve,
Cinzia,
Olav,
Herish
et al.:
PALLiON - PALLiative care Integrated in ONcology: Study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care
Sigve,
Tom
:
Krafttak mot kreft
14. März 2019
Tom,
Sigve
:
Jakter på kroppens krigerceller
18. September 2019
Tom,
Sigve
:
Jakter på kroppens krigerceller
05. September 2019
Sigve
:
Folkemøte om prostatakreft
2019
Kristin Benjaminsen,
Sigve,
Line Merethe,
Sveinung
:
Hva vet onkologer om fysisk aktivitet og kreft?
2019
Jan Henrik,
Olav,
Birthe Lie,
Anne Kari,
Peder,
Sigve
:
Nasjonalt handlingsprogram for palliasjon i kreftomsorgen
Helsedirektoratet 2019
Bente,
Tone,
Sigve
:
Fruktene av "Lindring i nord"
Kaja Konstanse,
Thea K.W.,
Mehrdad,
Elin,
Tom,
Thomas Karsten
et al.:
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
Steroids 2018 DOI
Sigve,
Tom,
Bodil,
Kari Margrethe,
Tone,
Bente
:
Palliative indicators in a university hospital - a cross-sectional prevalence study combined with ESAS-r symptom assesment and follow up of death
2017
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Translasjonell kreftforskning innen lunge og prostatakreft
Lindrende behandling